Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Gastroenterology & Hepatology|October 13, 2025
Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver DiseasesOzgur M Koc, Anne-Kristin Toussaint, Aurelie Untas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2024
Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R-LIVER)Ida Schregel, Maria Papp, Nora Sipeki, et al.
Digestive Diseases and Sciences|March 24, 2018
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune HepatitisCumali Efe, Haider Al Taii, Henriette Ytting, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 16, 2024
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver diseaseAnne-Sofie H Jensen, Henriette Ytting, Mikkel P Werge, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 17, 2023
Etiology and Outcome of Adult and Pediatric Acute Liver Failure in EuropeDominic Lenz, Marianne Hørby Jørgensen, Deirdre Kelly, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2025
Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical ProteomicsAnne-Sofie Houlberg Jensen, Henriette Ytting, Annelaura Bach Nielsen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune HepatitisCumali Efe, Hannes Hagström, Henriette Ytting, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
The American Journal of Gastroenterology|June 27, 2019
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CholangitisCumali Efe, Koray Taşçilar, Ida Henriksson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2020
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing CholangitisCharlotte Rose Hawkey Hedin, Gina Sado, Nelson Ndegwa, et al.
Pageof 5